PATENT CLAIM ANALYSIS

Application Number: 15964371
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "183000"]

Abstract:
A method of treating a subject having neuropathies and/or neuropathic pain, that includes administering a pharmaceutical composition or dietary supplement having, as the active ingredients,  Curcuma longa  extract, acetyl ester of L-carnitine and alpha-lipoic acidA is described.

Claim (Index 9):
The method of  claim 1 , wherein the pharmaceutical further comprises pharmaceutically acceptable excipients and/or binders and/or vehicles.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 91.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15503080', '15562991', '15503082', '13594128', '13933764']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7335038322964837
- 35 USC 102 Novelty (BERT): 0.6814224368981865
- Combined Prediction Score: 0.7282956927566541
- Mean Citation Score: 347.69894000000005
- Max Citation Score: 684.39624
- Similarity Product: 651.4496978297424

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test